v3.22.2.2

Earnings (Loss) Per Common Share (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2022
Earnings (Loss) Per Common Share [Abstract] |
Schedule of Earnings (loss) Per Share, Basic and Diluted | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended | ​
​ | ​ | June 30, | ​
​ | ​ | 2022 |  | 2021 | ​
Basic and diluted numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss attributable to iBio, Inc. | ​ | $ | (50,303) |  | $ | (23,207) | ​
Preferred stock dividends – iBio CMO Preferred Tracking Stock | ​ |  | (88) | ​ |  | (260) | ​
Net loss available to iBio, Inc. stockholders | ​ | $ | (50,391) | ​ | $ | (23,467) | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Basic and diluted denominator: | ​ |  | ​ | ​ |  | ​ | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Weighted-average common shares outstanding | ​ |  | 8,721 | ​ |  | 7,825 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Per share amount | ​ | $ | (5.78) | ​ | $ | (3.00) | ​
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | In Fiscal Years 2022 and 2021, the Company incurred net losses which cannot be diluted; therefore, basic and diluted loss per common share is the same. As of June 30, 2022 and 2021, shares issuable which could potentially dilute future earnings included were as follows:
​ | ​ | ​ | ​ | ​
​ | ​ | June 30,
​ |  | 2022 |  | 2021
​ | ​ | (in thousands)
Stock options |  | 622 |  | 342
Warrant issued under the Transaction |  | 51 |  | —
Restricted stock units |  | 21 |  | 27
Series 2022 Preferred | ​ | * | ​ | —
Shares excluded from the calculation of diluted loss per share |  | 694 |  | 369
​ | ​ | ​ | ​ | ​
* Less than 1,000 | ​ | ​ | ​ | ​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration